Home›Stock Screener›Sudarshan Pharma Industries

Sudarshan Pharma Industries Share Price Today | Stock Price & Sudarshan Pharma Industries Share Screener

SUDARSHAN Specialty Chemicals
Live Share Price NSE
₹30.94
▼ -0.48 (-1.53%)
2026-11-19 00:00:00
Live Share Price BSE
₹31.26
▲ 0.18 (0.58%)
2026-11-19 00:00:00

As of November 19, 2026, the live Sudarshan Pharma Industries share price (NSE: SUDARSHAN) is ₹30.94 on NSE and ₹31.26 on BSE, down 1.53% from the previous close, with shares trading between ₹30.40 and ₹32.18 in today's trading session, and a 52-week range of ₹30.94–₹37.92. Track Sudarshan Pharma Industries market worth to gauge the company's total market size. Use the Sudarshan Pharma Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sudarshan Pharma Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹219 and net income of ₹8, with EBITDA of ₹23, an operating margin of 9.0% and a profit margin of 3.7%.

Sudarshan Pharma Industries Market Cap ₹796.49 Cr.
SUDARSHAN P/E Ratio (TTM) 28.30
Sudarshan Pharma Industries P/B Ratio 4.19
EPS (TTM) ₹0.97
Dividend Yield 0.93%
Debt to Equity 1.60
SUDARSHAN 52 Week High ₹37.92
Sudarshan Pharma Industries 52 Week Low ₹30.94
Operating Margin 9.00%
Profit Margin 3.65%
SUDARSHAN Revenue (TTM) ₹219.00
EBITDA ₹23.00
Net Income ₹8.00
Total Assets ₹642.00
Total Equity ₹156.00

Sudarshan Pharma Industries Share Price Chart

Track the current stock price of Sudarshan Pharma Industries with an interactive chart. Analyse SUDARSHAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sudarshan Pharma Industries stock quote in one place.

The quote of ₹30.94 sits between the 52-week low of ₹30.94 and the 52-week high of ₹37.92, and the latest session moved -1.53% from the previous close.

Sudarshan Pharma Industries Company Profile - Fundamental Screener

Screen Sudarshan Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUDARSHAN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE00TV01023.

Company Details

Classification

Sector Chemicals
Industry Specialty Chemicals
Sub-Sector Specialty Chemicals
Segment E

Identifiers and Leadership

ISIN INE00TV01023

Sudarshan Pharma Industries Balance Sheet Screener

Screen SUDARSHAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹642, up from ₹402 in 2025.

Latest statistics put total assets at ₹642 and shareholder funds at ₹156, with a leverage ratio of 1.60.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 642 402 283 233 138 99 58
Current Assets 0 0 0 0 0 0 0
Fixed Assets 104 24 26 20 7 6 6

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 29 11 11 13 5 6 7
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 156 132 112 101 30 23 20
Share Capital 24 24 24 24 10 10 10
Reserves & Surplus 127 104 88 77 20 13 10

Sudarshan Pharma Industries Income Statement Screener - Profit & Revenue Analysis

Screen Sudarshan Pharma Industries income statement and profit fundamentals. Analyze SUDARSHAN quarterly results. Sudarshan Pharma Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹219 and net profit was ₹8, equal to earnings per unit of ₹0.31, at an operating margin of 9%.

In that period expenses were ₹196, interest cost ₹10 and tax ₹3. The next period listed, 2026-Jun, shows revenue of ₹176 and net profit of ₹6.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar

Revenue and Expenses

Revenue 219 176 225 170 171 147 162 116 129 100 232
Expenses 196 159 201 157 160 134 147 108 117 97 217

Operating Costs and Margins

EBITDA 23 17 24 12 11 12 15 9 12 3 15
Operating Profit % 9.00% 9.00% 9.00% 6.00% 5.00% 8.00% 9.00% 7.00% 9.00% 2.00% 6.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1
Interest 10 8 8 6 6 6 4 4 4 4 6

Profit and Earnings

Profit Before Tax 11 8 16 5 4 5 10 4 8 -2 9
Tax 3 2 4 1 0 1 3 1 2 0 2
Net Profit 8 6 11 4 4 4 7 3 6 -1 7
EPS 0.31 0.23 0.48 0.18 0.16 0.16 0.29 0.12 0.24 -0.05 0.27

Sudarshan Pharma Industries Cash Flow Screener - Liquidity Fundamentals

Screen SUDARSHAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹2, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹76 and financing activities provided ₹79.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities -2 -32 6 -29 -4 3 1
Investing Activities -76 -21 -6 -26 -2 -1 -3

Financing and Net Cash

Financing Activities 79 53 -12 66 4 -2 0
Net Cash Flow 1 0 -12 12 -1 0 -2

Sudarshan Pharma Industries Shareholding Pattern Screener

See Sudarshan Pharma Industries shareholding pattern with promoter, FII, and DII holdings. Check Sudarshan Pharma Industries promoter holding and ownership changes for SUDARSHAN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 57.81%, foreign institutions 21.95%, domestic institutions 0.00% and the public 16.58%, spread across 1,250 shareholders.

The shareholder count was 1,250 in 2026-Sept, compared with 1,217 in 2026-Aug.

Item 2026-Sept 2026-Aug 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar

Promoter Holding

Promoter Holding 57.81% 58.93% 58.93% 57.39% 57.39% 57.39% 57.39% 57.39%

Institutional Investors

FII Holding 21.95% 0.00% 19.38% 19.95% 19.78% 20.79% 19.48% 18.45%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.00%
Public Holding 16.58% 17.27% 16.37% 16.41% 16.88% 16.30% 17.14% 18.18%
Other Holding 3.61% 23.75% 5.27% 6.20% 5.90% 5.46% 5.94% 5.98%
Shareholder Count 1,250 1,217 1,231 1,346 1,407 1,383 1,327 1,212

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sudarshan Pharma Industries. Sudarshan Pharma Industries dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.30 4.05%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sudarshan Pharma Industries Stock Index Membership - Nifty & Sensex

See which indices include Sudarshan Pharma Industries stock. Check SUDARSHAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sudarshan Pharma Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Sudarshan Pharma Industries Market Events Screener - Corporate Actions

Get Sudarshan Pharma Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sudarshan Pharma Industries stock events that may affect SUDARSHAN share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 29, 2026, with a record date of October 29, 2026.

It is followed by Annual General Meeting dated September 22, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-29 2026-10-29 Quarterly Result Announcement NA 20.35%
2026-09-22 2026-09-22 Annual General Meeting NA 0.18%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -0.26%
2026-04-30 2026-04-30 Quarterly Result Announcement NA -0.96%
2026-01-28 2026-01-28 Quarterly Result Announcement NA -0.93%
2025-10-18 2025-10-18 Quarterly Result Announcement NA -2.36%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.00%
2025-08-11 2025-08-11 Extraordinary General Meeting NA 2.74%
2025-07-25 2025-07-25 Annual General Meeting NA -8.80%
2025-06-12 2025-06-12 Extraordinary General Meeting NA 4.14%
2025-04-24 2025-04-24 Quarterly Result Announcement NA -5.82%
2025-02-04 2025-02-04 Extraordinary General Meeting NA -19.06%
2024-11-23 2024-11-23 Split 1:10 4.99%
2024-10-31 2024-10-31 Quarterly Result Announcement NA 9.01%
2024-09-30 2024-09-30 Annual General Meeting NA -0.07%

Sudarshan Pharma Industries Competitors Screener - Peer Stocks Comparison

Screen SUDARSHAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 2 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sudarshan Pharma Industries 796 28.30 712 40.23% 23 36.35
Vahh Chemicals 40 8.10 43 82.28% 5 48.47

Sudarshan Pharma Industries Company Announcements - News & Reports Screener

Screen SUDARSHAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 13, 2026.

The next most recent announcements are dated November 11, 2026 and November 6, 2026.

Date Update Actions
2026-11-13 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-11-11 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-30 Announcement under Regulation 30 (LODR)-Issue of Securities -
2026-10-30 Announcement under Regulation 30 (LODR)-Issue of Securities -
2026-10-29 Financial Results For The Quarter Ended 30-Sep-2026 -
2026-10-26 Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 29Th October 2026 -
2026-10-23 Updates On Migration From SME Platform Of BSE To Capital Market Segment (Main Board) Of National Stock Exchange Of India Limited Of Sudarshan Pharma Industries Limited - Company Letter Bearing Ref. No. SPIL/CS/SE/2026-2027/20 Dated 21St May 2026 -
2026-10-07 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-30 Closure of Trading Window -
2026-09-28 Announcement under Regulation 30 (LODR)-Diversification / Disinvestment -
2026-09-22 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-22 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-22 Proceedings Of Annual General Meeting Held On 22/SEPT/2026 -
2026-09-15 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-09-09 Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-09-09 Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-09-05 Announcement under Regulation 30 (LODR)-Acquisition -
2026-09-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹30.94, within a 52-week range of ₹30.94 to ₹37.92. The P/E ratio is 28.30 and the P/B ratio is 4.19, with earnings per unit of ₹0.97. Market capitalisation stands at ₹796.49 Cr and the dividend yield is 0.93%. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 7 balance sheet periods, 11 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.